OpenTable (OPEN) Tops Today's Hot Stocks to Watch - Get the Updates Here

Hot Stocks to Watch, June 13, 2014: OpenTable Inc. (Nasdaq: OPEN) stock is on fire today - up around 50% in trading on news of a deal with Priceline Group Inc. (Nasdaq: PCLN).

Also topping today's hot stock news: It's Friday the 13th with a full moon, a rare occurrence that hasn't happened since 1919 and won't happen again until 2049, according to

Several studies have looked at the very plausible idea that the stock market might perform poorly on Friday the 13th, because of investors' superstitions. But, markets actually do slightly better, on average, than on others days.

Regardless of moon activity and what the calendar says, the following 12 "hot stocks to watch" are poised to do better today thanks to company news, analysts' actions, and M&A activity.

12 Hot Stocks to Watch Today

open hot stocksOpenTable Inc. (Nasdaq: OPEN) shares surged nearly 50% to a new high of $104.19 on brisk volume. Priceline Group Inc. (Nasdaq: PCLN) is buying the restaurant reservation service for $2.6 billion. PCLN, an online discount travel service giant, will pay $103 per share in cash, a 46% premium on OPEN's closing price on Thursday. "OpenTable is a great match for The Priceline Group," Darren Huston, Priceline chief executive officer, said in a statement. "They provide us with a natural extension into restaurant marketing services and a wonderful and highly valued booking experience for all our global customers." While PCLN shares slipped 1.2%, other companies in the online business sector moved higher. Review site Yelp Inc. (Nasdaq: YELP) shares surged 15% to $75.25. Daily deals site Groupon Inc. (Nasdaq: GRPN) shares climbed 5.58% to $6.39. And, services evaluator Angie's List Inc. (Nasdaq: ANGI) shares rose 2% to $13.04.

Abengoa Yield Plc. (Nasdaq: ABY) kicks off today's hot stocks to watch. The UK-based renewable energy company made its debut on the Nasdaq after pricing 24.85 million shares at $29 each. Shares opened at $35.16. By midmorning, following the successful initial public offering, ABY shares were up some 26% to $36.45.

Money Morning Members - keep reading. If you aren't already a Money Morning Member, sign up to get 10 more of the hot stocks to watch today - and you'll get our free guide: The Absolute Beginner's Guide to Trading and Investing

Allergan Inc. (NYSE: AGN) stock rose nearly 2% to $163.24 on hopes the recent push from William Ackman's Pershing Square Capital Management LP for a special meeting of Allergan shareholders will trigger the Botox maker's poison pill and work to Allergan's advantage. Pershing has called for a special meeting of AGN shareholders in an effort to unseat six members of the board as part of its takeover attempt with Valeant Pharmaceuticals Intl. Inc. (NYSE: VRX), which Allergan has repeatedly rebuffed.

The Boeing Co. (NYSE: BA) shares rose 0.37% to $133.68 after rating agency Moody's said Emirates' cancellation of a $16 billion order for 70 A2350 planes from Airbus Group NV (EPA: AIR) was a "credit negative" for the European plane marker and a "credit positive" development for Airbus rival Boeing. Moody's said the decision suggested more clearly the preference of at least one leading airline operating in the rapidly growing Middle East market for the Boeing 777x over Airbus' competing A350XWB.

Citigroup Inc. (NYSE: C) shares climbed 0.66% to $48.60 after the bank said it reached a deal to sell its consumer banking business in Greece, as well as its Diner Club of Greece SA credit unit, to Alpha Bank. The deal includes 480,000 customers, $1.4 billion in deposits, and $540 million in card and loan accounts. Alpha Bank, Greece's fourth-biggest lender by assets, will also receive Citi's 730 consumer banking employees, as well as the branch and automated teller machine network. The deal is expected to close in Q3. The move is part of Citi's initiative to focus more on its core international operations.

C.R. Bard Inc. (NYSE: BCR) rose 1% to 142.60 intraday. A U.S. Food and Drug Administration advisory committee unanimously recommended the use of C.R. Bard's Lutonix drug-coated balloon percutaneous transluminal angioplasty (PTA) catheter to treat patients with femoral and popliteal arterial blockages.

Intel Corp. (Nasdaq: INTC) shares were up nearly 7% to a 10-year high of $29.90 in morning trading. The chipmaker raised its outlook for the second quarter and full fiscal year, citing that demand for personal computers by businesses is stronger than first anticipated. INTC now expects to generate $13.7 billion in revenue in Q2, up from prior estimates of $13 billion. For FY2014, INTC said it now expects some growth in revenue compared with its previous expectation of approximately flat revenue. The company sees gross margin for the entire year to be in the upper half of the previous range of 61% due to anticipated improvements in unit costs and volume. Roth Capital upgraded INTC to "Buy" from "Neutral" with a $35 price target. Morgan Stanley, meanwhile, boosted its rating on the chipmaker to "Equal Weight."

Google Inc. (Nasdaq: GOOG, GOOGL) shares ticked up 1% right out of the gate to $560.85. The Internet behemoth is expected to announce a new service in about two weeks called Google Fit. Google Fit will be a service that collects all the data from all of your health-tracking gadgets. Apple Inc. (Nasdaq: AAPL) announced a similar feature at its World Wide Developers Conference earlier this month called HealthKit, which will be bundled into its new operating system. In April, Facebook Inc. (Nasdaq: FB) purchased Moves app in an attempt to also compete in fitness tracking.

Owens-Illinois Inc. (NYSE: OI) shares climbed 1.5% to $33.50 after Bank of America upgraded the container products manufacturer to "Buy" from "Neutral" with a $38.00 price target. BofA's price target suggests a potential 16% upside from the company's current price.

Robert Half International Inc. (NYSE: RHI) shares inched up 0.5% to $47.43 after RBC Capital Markets hiked its price target on the staffing and risk consulting company to $55.

Vivus Inc. (Nasdaq: VVUS) shares rose more than 2% to $5.39 after the small-cap biopharmaceutical company reported it has filed a lawsuit against Actavis Plc. (NYSE: ACT) for infringement of Qsymia patents. Qsymia is Vivus' key anti-obesity drug.

The Walt Disney Co. (NYSE: DIS) shares were little changed at $82.81 despite news the company expects global retail sales from its 10-month old "Infinity" video game to reach $1 billion, even as rivals also combine physical toys with video games. Disney launched "Infinity" in August to help turn around its interactive gaming unit, which lost $1.4 billion from 2008-2013. In May, Disney reported global retail sales of $550 million for "Infinity." Sales of the game helped the interactive unit post a $15 million profit for the quarter that ended in March, its third consecutive quarterly profit. "We will be a billion-dollar franchise," Jimmy Pitaro, president of Disney's interactive unit, said this week at the E3 video game conference.

Download your free Member report: The Absolute Beginner's Guide to Trading and Investing